We are live on ! Find out more
GNPX icon

Genprex

10 hedge funds and large institutions have $79.7K invested in Genprex in 2024 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 3

25% more funds holding

Funds holding: 810 (+2)

0% less ownership

Funds ownership: 0.01%0.01% (-0%)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

84% less capital invested

Capital invested by funds: $510K → $79.7K (-$431K)

Holders
10
Holders Change
+2
Holders Change %
+25%
% of All Funds
0.14%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
1
Reduced
1
Closed
3
Calls
Puts
Net Calls
Net Calls Change

GNPX Hedge Fund Activity: Q3 2024 in Review

10 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Genprex (GNPX) for Q3 2024, worth a combined $79.7K — down 84% from $510K a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new GNPX positions and 3 closed out — a net gain of 2 holders — while 1 added to existing stakes and 1 trimmed.

The largest buyer was UBS Group, opening a new position worth an estimated $63K. The largest seller was Armistice Capital, exiting entirely with an estimated $411K sold.

  • 10 institutional investors held Genprex (GNPX) as of Q3 2024, up from 8 in Q2 2024.
  • Funds reported $79.7K of Genprex stock for Q3 2024, down 84% quarter-over-quarter.
  • 5 funds opened new Genprex positions in Q3 2024 and 3 closed out, a net change of +2 holders.
  • The largest Genprex buyer in Q3 2024 was UBS Group, an estimated $63K added.
  • The largest Genprex seller in Q3 2024 was Armistice Capital, an estimated $411K sold.

Based on aggregated 13F filings for Q3 2024.